Pediatric vascularized composite allotransplantation.

Area of Science:

• Surgical Innovation
• Pediatric Transplantation
• Immunosuppression Research

Background:

• Vascularized composite allotransplantation (VCA) acceptance is growing, prompting discussion on pediatric application.
• Evidence from pediatric solid organ transplantation and adult VCA informs this debate.

Purpose of the Study:

• To discuss the potential indications for pediatric VCA.
• To evaluate the risks and benefits based on existing pediatric and adult transplant data.

Main Methods:

• Review of literature on pediatric solid organ transplantation outcomes.
• Analysis of studies on pediatric reconstructive surgery, including limb replantation and craniofacial procedures.
• Examination of adult VCA outcomes and complications.

Main Results:

• Pediatric solid organ transplants have limited lifespans and long-term immunosuppression risks (infections, metabolic disorders, malignancy).
• Pediatric VCA recipients face risks of growth impairment, learning disabilities, and medication nonadherence.
• Facial VCA may cause midfacial growth arrest; limb VCA may allow normal growth.

Conclusions:

• Current immunosuppressive protocols present substantial risks for pediatric VCA recipients.
• Given the non-life-threatening nature of indications, extending VCA to children is currently inadvisable.